ArticleFrontiers in immunology2021

Teriflunomide Treatment of Multiple Sclerosis Selectively Modulates CD8 Memory T Cells.

Gaëlle Tilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.